p53/HMGB1 complexes regulate autophagy and apoptosis.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 3417120)

Published in Cancer Res on February 16, 2012

Authors

Kristen M Livesey1, Rui Kang, Philip Vernon, William Buchser, Patricia Loughran, Simon C Watkins, Lin Zhang, James J Manfredi, Herbert J Zeh, Luyuan Li, Michael T Lotze, Daolin Tang

Author Affiliations

1: Department of Surgery, Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.

Articles citing this

PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev (2012) 2.24

Metabolic regulation by p53 family members. Cell Metab (2013) 2.00

HMGB1 in cancer: good, bad, or both? Clin Cancer Res (2013) 1.79

HMGB1 in health and disease. Mol Aspects Med (2014) 1.67

The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene (2013) 1.43

Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis (2013) 1.25

Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. Mol Med (2013) 1.17

Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid Redox Signal (2012) 1.11

HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene (2015) 1.07

Autophagy in pancreatic cancer pathogenesis and treatment. Am J Cancer Res (2012) 1.07

Role of the Crosstalk between Autophagy and Apoptosis in Cancer. J Oncol (2013) 1.07

DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy (2013) 1.02

HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. Mol Cancer (2014) 1.02

Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res (2013) 1.01

Autophagy in inflammation, infection, neurodegeneration and cancer. Int Immunopharmacol (2013) 1.00

miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2. Cell Death Dis (2015) 1.00

MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell. Autophagy (2014) 0.99

Regulation of the autophagic bcl-2/beclin 1 interaction. Cells (2012) 0.98

Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway. Oncotarget (2014) 0.96

HMGB1-dependent and -independent autophagy. Autophagy (2014) 0.94

You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia. Leukemia (2014) 0.93

HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway. Cancer Biol Ther (2015) 0.92

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol (2016) 0.89

Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. PLoS One (2014) 0.89

Ménage à Trois in stress: DAMPs, redox and autophagy. Semin Cancer Biol (2013) 0.89

Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates. J Immunol (2013) 0.89

p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses. Mol Cell Proteomics (2015) 0.86

Recent discoveries in the cycling, growing and aging of the p53 field. Aging (Albany NY) (2012) 0.85

Activation of p53 with ilimaquinone and ethylsmenoquinone, marine sponge metabolites, induces apoptosis and autophagy in colon cancer cells. Mar Drugs (2015) 0.85

Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep (2014) 0.84

High mobility group box 1 (HMGB1) phenotypic role revealed with stress. Mol Med (2014) 0.83

Profiling drug-induced cell death pathways in the zebrafish lateral line. Apoptosis (2013) 0.82

Lymphatics, lymph nodes and the immune system: barriers and gateways for cancer spread. Clin Exp Metastasis (2012) 0.82

Survivin-2B promotes autophagy by accumulating IKK alpha in the nucleus of selenite-treated NB4 cells. Cell Death Dis (2014) 0.82

Autophagy and transporter-based multi-drug resistance. Cells (2012) 0.82

Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer. Pancreas (2013) 0.81

DAMPs, ageing, and cancer: The 'DAMP Hypothesis'. Ageing Res Rev (2014) 0.81

Aging and uremia: Is there cellular and molecular crossover? World J Nephrol (2015) 0.80

Structure-Based Analysis Reveals Cancer Missense Mutations Target Protein Interaction Interfaces. PLoS One (2016) 0.80

HMGB1-DNA complex-induced autophagy limits AIM2 inflammasome activation through RAGE. Biochem Biophys Res Commun (2014) 0.80

HMGB1 promotes HCC progression partly by downregulating p21 via ERK/c-Myc pathway and upregulating MMP-2. Tumour Biol (2015) 0.79

High Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate Cancer. Oxid Med Cell Longev (2015) 0.79

The molecular mechanisms between autophagy and apoptosis: potential role in central nervous system disorders. Cell Mol Neurobiol (2014) 0.79

Salternamide A Suppresses Hypoxia-Induced Accumulation of HIF-1α and Induces Apoptosis in Human Colorectal Cancer Cells. Mar Drugs (2015) 0.78

Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival. Biosci Rep (2015) 0.78

Downregulation of Beclin 1 and impairment of autophagy in a small population of colorectal cancer. Dig Dis Sci (2013) 0.78

Targeting metabolism and autophagy in the context of haematologic malignancies. Int J Cell Biol (2012) 0.77

HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications. Sci Rep (2016) 0.77

HMGB1 Promotes Mitochondrial Dysfunction-Triggered Striatal Neurodegeneration via Autophagy and Apoptosis Activation. PLoS One (2015) 0.77

Poly-ADP-ribosylation of HMGB1 regulates TNFSF10/TRAIL resistance through autophagy. Autophagy (2015) 0.76

Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer. Cells (2012) 0.76

Potential role of High mobility group box 1 in hepatocellular carcinoma. Cell Adh Migr (2014) 0.75

CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma. World J Gastroenterol (2017) 0.75

RelA-Mediated BECN1 Expression Is Required for Reactive Oxygen Species-Induced Autophagy in Oral Cancer Cells Exposed to Low-Power Laser Irradiation. PLoS One (2016) 0.75

Lycorine Downregulates HMGB1 to Inhibit Autophagy and Enhances Bortezomib Activity in Multiple Myeloma. Theranostics (2016) 0.75

Anticancer Effects of the Marine Sponge Lipastrotethya sp. Extract on Wild-Type and p53 Knockout HCT116 Cells. Evid Based Complement Alternat Med (2017) 0.75

Expression pattern of HMGB1 and its association with autophagy in acute necrotizing pancreatitis. Mol Med Rep (2016) 0.75

HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model. Front Mol Neurosci (2017) 0.75

The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget (2017) 0.75

Oxidative stress-dependent contribution of HMGB1 to the interplay between apoptosis and autophagy in diabetic rat liver. J Physiol Biochem (2017) 0.75

Articles cited by this

The biochemistry of apoptosis. Nature (2000) 18.91

p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol (2005) 18.23

Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell (1995) 14.90

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 11.57

Autophagy and the integrated stress response. Mol Cell (2010) 11.21

Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88

Autophagy suppresses tumorigenesis through elimination of p62. Cell (2009) 9.95

Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science (2004) 9.52

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell (2006) 9.47

Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol (2006) 8.89

Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol (2004) 8.85

Eaten alive: a history of macroautophagy. Nat Cell Biol (2010) 8.83

Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol (2008) 6.78

Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97

p62 at the crossroads of autophagy, apoptosis, and cancer. Cell (2009) 5.97

The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ (2011) 5.95

PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science (2005) 5.49

p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A (1990) 5.43

Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res (2011) 5.40

Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol (2004) 5.31

Cytoplasmic functions of the tumour suppressor p53. Nature (2009) 5.23

Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A (2002) 3.68

Apoptosis - the p53 network. J Cell Sci (2003) 3.64

Signal integration and diversification through the p62 scaffold protein. Trends Biochem Sci (2006) 3.50

High-mobility group box 1 and cancer. Biochim Biophys Acta (2010) 3.11

HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene (2010) 2.91

HMGB1 promotes drug resistance in osteosarcoma. Cancer Res (2011) 2.82

Autophagy regulation by p53. Curr Opin Cell Biol (2010) 2.56

Integrated endoplasmic reticulum stress responses in cancer. Cancer Res (2007) 2.43

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ (2009) 2.30

High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19

p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene (2003) 2.17

High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab (2011) 1.89

Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs (2009) 1.79

Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb Chem High Throughput Screen (2009) 1.78

p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation. Proc Natl Acad Sci U S A (2010) 1.77

The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci U S A (2007) 1.73

Upregulation of human autophagy-initiation kinase ULK1 by tumor suppressor p53 contributes to DNA-damage-induced cell death. Cell Death Differ (2011) 1.33

High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxid Redox Signal (2011) 1.27

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. J Cancer Res Clin Oncol (2009) 1.26

p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. Eur J Cancer (2011) 1.25

Apoptosis promotes early tumorigenesis. Oncogene (2010) 1.11

Tumor-cell death, autophagy, and immunity. N Engl J Med (2012) 1.10

The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid Redox Signal (2011) 1.05

High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops. Biochemistry (2004) 1.05

The acidic C-terminal domain and A-box of HMGB-1 regulates p53-mediated transcription. Nucleic Acids Res (2003) 0.96

DNA repair pathway profiling and microsatellite instability in colorectal cancer. Clin Cancer Res (2006) 0.92

Articles by these authors

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Genomewide association study of leprosy. N Engl J Med (2009) 8.17

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol (2008) 7.86

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature (2003) 7.69

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86

Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 6.59

Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood (2011) 5.82

Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet (2003) 5.51

Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res (2011) 5.40

Interleukin-17 promotes angiogenesis and tumor growth. Blood (2002) 4.90

Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA (2004) 4.88

Endogenous HMGB1 regulates autophagy. J Cell Biol (2010) 4.71

PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A (2003) 4.46

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature (2011) 4.07

Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique. Ann Surg (2013) 3.94

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther (2007) 3.93

Inflammation and necrosis promote tumour growth. Nat Rev Immunol (2004) 3.68

Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood (2004) 3.68

Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet (2009) 3.59

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med (2004) 3.55

The TLR4 gene polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Eur J Cancer (2012) 3.41

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One (2010) 3.38

Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death. Circ Res (2005) 3.34

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev (2007) 3.33

RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A (2004) 3.25

High-mobility group box 1 and cancer. Biochim Biophys Acta (2010) 3.11

Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem (2004) 3.06

IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol (2005) 3.02

Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.02

Interleukin-12: biological properties and clinical application. Clin Cancer Res (2007) 3.00

Expanding window compressed sensing for non-uniform compressible signals. Sensors (Basel) (2012) 2.98

CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol (2002) 2.94

HMGB1 promotes drug resistance in osteosarcoma. Cancer Res (2011) 2.82

Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol (2007) 2.81

Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol (2005) 2.78

Fragile X-associated tremor/ataxia syndrome: clinical features, genetics, and testing guidelines. Mov Disord (2007) 2.68

PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell (2008) 2.68

Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J Immunol (2006) 2.68

Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death. Circ Res (2002) 2.64

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med (2009) 2.56

Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J (2002) 2.53

Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42

Masquerader: high mobility group box-1 and cancer. Clin Cancer Res (2007) 2.40

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res (2008) 2.35

Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet (2004) 2.32

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res (2009) 2.32

Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32

Mechanisms of microRNA deregulation in human cancer. Cell Cycle (2008) 2.30

Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem (2005) 2.28

The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun (2005) 2.25

PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev (2012) 2.24

A homochiral porous metal-organic framework for highly enantioselective heterogeneous asymmetric catalysis. J Am Chem Soc (2005) 2.24

Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol Bioeng (2010) 2.23

Epsin 1 is a polyubiquitin-selective clathrin-associated sorting protein. Traffic (2006) 2.20

High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19

ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. Ann Thorac Surg (2012) 2.18

Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J Leukoc Biol (2006) 2.17

The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol (2006) 2.15

Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res (2006) 2.15

FSIM: a feature similarity index for image quality assessment. IEEE Trans Image Process (2011) 2.13

Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol (2007) 2.12

HISTONE DEACETYLASE19 is involved in jasmonic acid and ethylene signaling of pathogen response in Arabidopsis. Plant Cell (2005) 2.06

Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. J Biol Chem (2003) 2.04

Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood (2002) 2.02

PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem (2006) 2.02

Regulation of Sar1 NH2 terminus by GTP binding and hydrolysis promotes membrane deformation to control COPII vesicle fission. J Cell Biol (2005) 1.99

Multiple roles of the tumor suppressor p53. Curr Opin Oncol (2002) 1.99

Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res (2011) 1.99

Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res (2011) 1.98

Telephone-based re-education on the day before colonoscopy improves the quality of bowel preparation and the polyp detection rate: a prospective, colonoscopist-blinded, randomised, controlled study. Gut (2013) 1.97

KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol (2009) 1.97

Relationships of Indoor, Outdoor, and Personal Air (RIOPA). Part I. Collection methods and descriptive analyses. Res Rep Health Eff Inst (2005) 1.95

Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet (2011) 1.95

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma. Blood (2012) 1.94

Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proc Natl Acad Sci U S A (2009) 1.94

Redistribution of pulmonary EC-SOD after exposure to asbestos. J Appl Physiol (1985) (2004) 1.92

Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine (2002) 1.92

NF-κB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest (2012) 1.91

High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab (2011) 1.89